Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Metformin in Alzheimer's Dementia PreventionCognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, cognitive disorder, psychiatric disorderActive, not recruitingPhase 2 / Phase 32026-08-11NCT04098666

27 results · Page 1 of 2

Swipe the table sideways for more columns.

22 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Boston UniversityBostonUnited States11
Columbia University Medical centerNew YorkUnited States224
Cornell UniversityNew YorkUnited States10
Eastern Virginia Medical SchoolNorfolkUnited States8
Emory UniversityAtlantaUnited States27
Georgetown UniversityWashington D.C.United States38
Medical College of WisconsinMilwaukeeUnited States483
New York University Langone Medical CenterNew YorkUnited States23
Pennington Biomedical Research CenterBaton RougeUnited States43
Rush University Medical CenterChicagoUnited States283
Stanford UniversityPalo AltoUnited States161
SUNY Upstate Medical UniversitySyracuseUnited States68
The University of Texas Health Science Center San AntonioSan AntonioUnited States5
University At BuffaloBuffaloUnited States20
University of California - IrvineIrvineUnited States3
University of CincinnatiCincinnatiUnited States79
University of Kansas Medical CenterWichitaUnited States1
University of MiamiMiamiUnited States327
University of New MexicoAlbuquerqueUnited States17
University of Texas - Southwestern Medical CenterDallasUnited States2
University of WashingtonSeattleUnited States31
Wake Forest University Health SciencesWinston-SalemUnited States330